| TTM
|
6/30/2026
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
80,448 | 80,448 | 110,598 | 131,532 | 180,051 |
|
Cost of Revenue
|
-67,046 | -67,046 | -69,139 | -80,631 | -104,270 |
|
Gross Profit
|
13,402 | 13,402 | 41,459 | 50,901 | 75,781 |
| Selling, General and Administrative Expenses
|
-73,117 | -73,117 | -32,559 | -32,316 | -34,475 |
| Other Income/Expense, Operating
|
5,244 | 5,244 | 3,325 | 10,506 | 7,973 |
|
Operating Income/Expenses
|
-67,873 | -67,873 | -29,234 | -21,810 | -26,502 |
|
Total Operating Profit/Loss
|
-54,471 | -54,471 | 12,225 | 29,091 | 49,279 |
| Total Net Finance Income/Expense
|
1,034 | 1,034 | 4,156 | 4,941 | 2,276 |
| Net Investment Income
|
-3,144 | -3,144 | 252 | -130 | -281 |
|
Non-Operating Income/Expenses, Total
|
-2,110 | -2,110 | 4,408 | 4,811 | 1,995 |
|
Pretax Income
|
-56,581 | -56,581 | 16,633 | 33,902 | 51,274 |
|
Provision for Income Tax
|
171 | 171 | -5,825 | -7,487 | -5,810 |
|
Net Income from Continuing Operations
|
-56,410 | -56,410 | 10,808 | 26,415 | 45,464 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-56,410 | -56,410 | 10,808 | 26,415 | 45,464 |
|
Net Income after Non-Controlling/Minority Interests
|
-56,410 | -56,410 | 10,808 | 26,415 | 45,464 |
|
Net Income Available to Common Stockholders
|
-56,410 | -56,410 | 10,808 | 26,415 | 45,464 |
|
Diluted Net Income Available to Common Stockholders
|
-56,410 | -56,410 | 10,808 | 26,415 | 45,464 |
|
Common Dividend per Share
|
-- | -- | -- | 0.03 | 0.06 |
|
Special Dividend per Share
|
-- | -- | -- | 0.01 | -- |
| Basic EPS
|
-0.08 | -0.08 | 0.02 | 0.04 | 0.07 |
| Diluted EPS
|
-0.08 | -0.08 | 0.02 | 0.04 | 0.07 |
|
Basic Weighted Average Shares Outstanding
|
698,548 | 698,548 | 675,217 | 670,453 | 669,445 |
|
Diluted Weighted Average Shares Outstanding
|
698,548 | 698,548 | 675,217 | 670,898 | 669,500 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-57,615 | -57,615 | 12,477 | 28,961 | 48,998 |
|
EBITDA
|
-45,558 | -45,558 | 24,460 | 43,476 | 70,837 |
|
Normalized EBITDA
|
-18,458 | -18,458 | 24,397 | 43,312 | 72,961 |
|
Normalized Income
|
-29,391.8962 | -29,391.8962 | 10,767.0630 | 26,287.2181 | 47,347.3232 |
|
Total Unusual Items
|
27,100 | 27,100 | -63 | -164 | 2,124 |
|
Total Unusual Items Excluding Goodwill
|
27,100 | 27,100 | -63 | -164 | 2,124 |
12/31/2022 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade